Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T17:32:13.355Z.
Calculation as of: 2026-10-06T17:32:13.355Z.
Quote observation: 2026-10-06T17:30:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9eab42942c27d7457dfc33c45bb783e1a271ca5ab59202131f9efdd6250b8ad0
PEG RATIO
N/A
Healthcare Triangle, Inc.
Market Cap
$8.36M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Healthcare Triangle, Inc. (HCTI) | $8.36M | N/A |
| DataMEDS AI, Inc. (MEDS)vs › | $8.53M | N/A |
| HeartSciences Inc. (HSCS)vs › | $8.18M | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.13M | N/A |
| GT Biopharma, Inc. (GTBP)vs › | $7.95M | N/A |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $8.01M | N/A |
| Traws Pharma, Inc. (TRAW)vs › | $7.93M | N/A |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.81M | N/A |
| Jasper Therapeutics, Inc. (JSPR)vs › | $8.99M | N/A |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.43M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
